Published • loading... • Updated
As tick bites increase, drug company touts Lyme disease vaccine in the works
Pfizer and Valneva say the shot could be available next year if regulators approve it, as tick bites rise nationwide.
Summary by Spectrum News
5 Articles
5 Articles
Spectrum Local News+2 Reposted by 2 other sources
As tick bites increase, drug company touts Lyme disease vaccine in the works
In March, the pharmaceutical giant Pfizer reported 73% efficacy in a phase 3 clinical trial of its Vaccine Against Lyme for Outdoor Recreationists.
·United States
Read Full Article
Pfizer and Valneva are preparing for a decisive assault on the offices of the US regulator FDA to finally bring the first ever vaccine against Lyme disease to the market.
·Ukraine
Read Full Article
World's first vaccine for Lyme disease could be available in 2027
Based on the results of two completed Phase III trials, scientists are confident that we could see an effective vaccine against Lyme disease by next year.Continue ReadingCategory: Illnesses and conditions, Body and MindTags: Pfizer, Lyme disease, Drug delivery, Vaccines, clinical trials, Tick, Health
Coverage Details
Total News Sources5
Leaning Left0Leaning Right0Center3Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
